Search

The great potential for medical applications of inorganic nanoparticles in living organisms is severely restricted by the concern that nanoparticles can harmfully interact with biological systems, such as lipid membranes or cell proteins. To enable an uptake of such nanoparticles by cells without harming their membranes, platinum nanoparticles were synthesized within cavities of hollow protein nanospheres (apoferritin). In vitro, the protein-platinum nanoparticles show good catalytic efficiency and long-term stability. Subsequently the particles were tested after ferritin-receptor-mediated incorporation in human intestinal Caco-2 cells. Upon externally induced stress, for example, with hydrogen peroxide, the oxygen species in the cells decreased and the viability of the cells increased.

Cu nanoparticle chains encapsulated in Al2O3 nanotubes were successfully generated in a controlled manner by reduction of CuO nanowires embedded in Al2O3 at a sufficiently high temperature. The Al2O3 coating was deposited by atomic layer deposition (ALD). The particles mainly show a rodlike shape and are regularly distributed. The particle diameters and chain lengths corresponding to the inner diameters and lengths of the tubes, respectively, are controlled by the size of the CuO nanowire templates. Rayleigh instability, assisted by the uniform volume shrinkage created by the reduction of oxide to metal, is proposed to induce the formation of the nanochains. This method may potentially be extended to the synthesis of nanochains of other metals by reducing corresponding oxide nanowires embedded in ALD shells.